<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="letter" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">DRJ</journal-id>
<journal-title>Dental Research Journal</journal-title>
<issn pub-type="ppub">1735-3327</issn>
<issn pub-type="epub">2008-0255</issn>
<publisher>
<publisher-name>Medknow Publications &#x0026; Media Pvt Ltd</publisher-name>
<publisher-loc>India</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">DRJ-9-655</article-id>
<article-categories>
<subj-group subj-group-type="headings">
<subject>Letter to Editor</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Resveratrol as a supplemental treatment for periodontitis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Khazaei</surname>
<given-names>Saber</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Khazaei</surname>
<given-names>Mozafar</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kazemi</surname>
<given-names>Shantia</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yaghini</surname>
<given-names>Jaber</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label>Dental Students&#x2019; Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.</aff>
<aff id="aff2"><label>2</label>Fertility and Infertility Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.</aff>
<aff id="aff3"><label>3</label>Department of Periodontology, School of Dentistry, Isfahan University of Medical Sciences, Isfahan, Iran.</aff>
<author-notes>
<corresp id="cor1">
<bold>Address for correspondence:</bold> Miss. Shantia Kazemi, Dental Students&#x2019; Research Center, School of Dentistry, Isfahan University of Medical Sciences, Hezar Jerib Street, Post Code: 81746-73461, Isfahan, Iran. E-mail: <email xlink:href="shantia.kazemi1@gmail.com">shantia.kazemi1@gmail.com</email>
</corresp>
</author-notes>
<pub-date pub-type="ppub">
<season>Sep&#x2013;Oct</season>
<year>2012</year>
</pub-date>
<volume>9</volume>
<issue>5</issue>
<fpage>655</fpage>
<lpage>657</lpage>
<permissions>
<copyright-statement>Copyright: &#x000a9; Dental Research Journal</copyright-statement>
<copyright-year>2012</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
</license>
</permissions>
</article-meta>
</front>
<body>
<sec>
<title/>
<p>Dear Editor,</p>
<p>Periodontitis is a multifactorial disease caused by many factors such as oral micro-organisms, genetics disorders, tobacco and alcohol use, nutrition, diabetes, stress and impaired host response.[<xref ref-type="bibr" rid="ref1">1</xref>] The immune-inflammatory response, which is present in the gingival and periodontal tissues, causes destruction of structural components of the periodontium in response to chronic accumulation of plaque bacteria.[<xref ref-type="bibr" rid="ref2">2</xref>] Although components of periodonto pathogenic micro-organisms and products from the subgingival biofilm trigger the production of anti-inflammatory molecules, such as IL1-&#946;, IL-6, IL-8, and cyclooxygenase (COX)-2, but infiltrating immunoinflammatory and resident cells of the periodontium initiate and perpetuate soft tissue degradation and bone resorption.[<xref ref-type="bibr" rid="ref3">3</xref>] On the other hand, persistent microbial challenge in the presence of mentioned risk factors also results in the destruction of both soft and hard tissues by cytokine and prostanoid cascades. So active periodontitis can cause bone loss without sufficient treatment.[<xref ref-type="bibr" rid="ref1">1</xref>]</p>
<p>Resveratrol, trans-3,5,4&#x2019;-trihydroxy-trans-stilbene (C<sub>14</sub>H<sub>12</sub>O<sub>3</sub>) is a phytoalexin found in plants, and specially in skin of red grapes.[<xref ref-type="bibr" rid="ref4">4</xref>] It has been reported to exhibit a wide range of biological and pharmacological properties that regulates several metabolic pathways.[<xref ref-type="bibr" rid="ref5">5</xref>] The resveratrol properties includes aging control,[<xref ref-type="bibr" rid="ref6">6</xref>] anti-cancer effect, which affects all stages of carcinogenesis; tumor initiation, promotion and progression,[<xref ref-type="bibr" rid="ref7">7</xref>] cardiovascular protection[<xref ref-type="bibr" rid="ref8">8</xref>] and neuroprotective effect.[<xref ref-type="bibr" rid="ref9">9</xref>] Resveratrol inhibits inflammation and oxidative stress and platelet aggregation[<xref ref-type="bibr" rid="ref10">10</xref>] and it has a direct stimulatory effect on bone formation.[<xref ref-type="bibr" rid="ref11">11</xref>&#x2013;<xref ref-type="bibr" rid="ref13">13</xref>]</p>
</sec>
<sec id="sec1-1">
<title>HYPOTHESIS</title>
<p>Resveratrol promotes osteogenesis via direct effect on bone formation,[<xref ref-type="bibr" rid="ref11">11</xref>&#x2013;<xref ref-type="bibr" rid="ref13">13</xref>] and on the other hand, it shows anti-inflammatory and analgesic effect.[<xref ref-type="bibr" rid="ref14">14</xref><xref ref-type="bibr" rid="ref15">15</xref>] Thus, it can be hypothesized that resveratrol plays an important role in supplemental treatment of periodontitis. Successful treatment of periodontal diseases can be achieved by using resveratrol as a non-surgical treatment of periodontitis.</p>
<sec id="sec2-1">
<title>Background and Evidence</title>
<p>Inflammation that extends deep into the tissues and causes loss of supporting connective tissue and alveolar bone is known as periodontitis.[<xref ref-type="bibr" rid="ref1">1</xref>] Treatment of periodontitis should prevent recurrence of disease, which can be achieved by various non-surgical and surgical therapies depending on the specific treatment goal. Resveratrol can be considered as a supplemental method for non-surgical treatment of periodontitis due to its anti-inflammatory effects and stimulatory effects on osteoblastic cells.</p>
<p>Resveratrol stimulated osteoblastic proliferation and differentiation by increasing expression of Runx2, Ocn, Osterix genes, alkaline phosphatase (ALP) and prolyl hydroxylase in a dose-dependent manner.[<xref ref-type="bibr" rid="ref11">11</xref><xref ref-type="bibr" rid="ref16">16</xref><xref ref-type="bibr" rid="ref17">17</xref>] It also enhances the differentiation of osteoblasts from mesenchymal stem cells[<xref ref-type="bibr" rid="ref12">12</xref>] and inhibits adipogenesis.[<xref ref-type="bibr" rid="ref16">16</xref>]</p>
<p>Resveratrol induced ER signaling and ERK1/2 activity and increased osteogenic genes Runx2/cbfa1 expression, which is a critical transcription factor in the osteoblast differentiation.[<xref ref-type="bibr" rid="ref18">18</xref>] Biological effects of resveratrol are associated with MAPK signaling pathways, which are involved in human bone metabolism, including the commitment of Human bone marrow mesenchymal stem cells (HBMSCs) to the osteogenic lineages.[<xref ref-type="bibr" rid="ref19">19</xref>] Resveratrol also inhibited bone loss in ovariectomized rats.[<xref ref-type="bibr" rid="ref20">20</xref>] It also inhibits RANKL-induced osteoclast differentiation and bone resorption.[<xref ref-type="bibr" rid="ref16">16</xref><xref ref-type="bibr" rid="ref17">17</xref>] It is known that the presence of PGE2 or parathyroid hormone caused a significant decrease in bone ALP activity and a corresponding increase in bone acid phosphatase activity.[<xref ref-type="bibr" rid="ref11">11</xref>]</p>
<p>Resveratrol is a potent inhibitor of inflammatory molecules. Its anti-inflammatory properties is associated with inhibition of NF-kappa B in LPS, TNF-&#945;, or PMA-mediated macrophages, dendritic, myeloid (U-937), Jurkat, and epithelial (HeLa) cells.[<xref ref-type="bibr" rid="ref21">21</xref><xref ref-type="bibr" rid="ref22">22</xref>]</p>
<p>Resveratrol significantly suppresses the secretion of TNF-&#945; and nitric oxide in LPS-stimulated rat cortical microglia and N9 microglial cells[<xref ref-type="bibr" rid="ref23">23</xref>] and also inhibits the production of TNF-&#945;, IL-1, IL-6, IL-12 and IFN by splenic lymphocytes and macrophages.[<xref ref-type="bibr" rid="ref21">21</xref><xref ref-type="bibr" rid="ref24">24</xref>] Resveratrol also exhibits strong anti-inflammatory activity of C5 anaphylatoxin (C5a)-mediated inflammation <italic>in-vivo</italic> condition.</p>
<p>Additionally, resveratrol inhibits C5a-stimulated neutrophil migration/recruitment, and production of inflammatory cytokines in a mouse model of C5a-induced acute peritonitis.[<xref ref-type="bibr" rid="ref25">25</xref>]</p>
<p>Several effects of resveratrol including platelet aggregation attenuation,[<xref ref-type="bibr" rid="ref26">26</xref>] cardiovascular protection,[<xref ref-type="bibr" rid="ref8">8</xref>] and anti-cancer activity[<xref ref-type="bibr" rid="ref7">7</xref>] have been reported in the recent years.</p>
<p>Resveratrol shows inhibitory effects on the expression of cell adhesion molecules. Resveratrol attenuated the IL-6 induced expression of ICAM-1 in endothelial cells[<xref ref-type="bibr" rid="ref27">27</xref>] and also inhibited <italic>Porphyromonas gingivalis</italic> LPS-induced endothelial dysfunction in human microvascular endothelial cells. Furthermore, it blocked the expression of adhesion molecules, ICAM-1, and VCAM-1 on HMECs by inhibiting NF-kappa B activation.[<xref ref-type="bibr" rid="ref28">28</xref>]</p>
<p>The pathogenesis of inflammatory induced bone resorption has been attributed to local signals stimulating activity and recruitment of osteoclasts. These local factors include bacterial products such as lipopolysaccharides, lipoteichoic acid, and several peptides produced by invading leukocytes as well as factors from blood proteins. Bacterial products can all directly stimulate <italic>in-vitro</italic> bone resorption. Leukocytes present in inflammatory reactions produce several cytokines with bone resorption stimulatory activity. The monokines interleukin-1 and tumor necrosis factor &#945; (TNF- &#945;) enhance bone resorption <italic>in-vitro</italic>.[<xref ref-type="bibr" rid="ref29">29</xref>]</p>
<p>Periodontitis is an inflammatory disease of periodontal tissues, which is determined by inflammation extending deeply to the tooth supporting structures. It seems that resveratrol is influencing many factors and mediators involved in the pathogenesis of periodontitis. The degree of destruction caused by this disease depends on the interaction of microorganisms with host defense. Micro-organisms cause direct tissues destruction or immune response stimulation indirectly. The immune system&#x0027;s rule is to prevent the local infection from becoming a fetal systemic infection. According to all the matters mentioned above, it seems that induction of resveratrol whether systemic or by local delivery affects different aspects of periodontitis pathogenesis and can be useful by inhibiting the progression of periodontitis.</p>
</sec>
</sec>
</body>
<back>
<ref-list>
<title>REFERENCES</title>
<ref id="ref1">
<label>1</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pihlstrom</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Michalowicz</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>NW</given-names>
</name>
</person-group>
<article-title>Periodontal diseases</article-title>
<source>Lancet</source>
<year>2005</year>
<volume>366</volume>
<fpage>1809</fpage>
<lpage>20</lpage>
</nlm-citation>
</ref>
<ref id="ref2">
<label>2</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tanner</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Kent</surname>
<given-names>R</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>van Dyke</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Sonis</surname>
<given-names>ST</given-names>
</name>
<name>
<surname>Murray</surname>
<given-names>LA</given-names>
</name>
</person-group>
<article-title>Clinical and other risk indicators for early periodontitis in adults</article-title>
<source>J Periodontol</source>
<year>2005</year>
<volume>76</volume>
<fpage>573</fpage>
<lpage>81</lpage>
</nlm-citation>
</ref>
<ref id="ref3">
<label>3</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nokhbehsaim</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Deschner</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Winter</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bourauel</surname>
<given-names>C</given-names>
</name>
<name>
<surname>J&#228;ger</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Jepsen</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>
<article-title>Anti-inflammatory effects of EMD in the presence of biomechanical loading and interleukin-1&#946; <italic>in vitro</italic></article-title>
<source>Clin Oral Investig</source>
<year>2012</year>
<volume>16</volume>
<fpage>275</fpage>
<lpage>83</lpage>
</nlm-citation>
</ref>
<ref id="ref4">
<label>4</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vang</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Ahmad</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Baile</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Baur</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Csiszar</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>What is new for an old molecule&#x003F; Systematic review and recommendations on the use of resveratrol</article-title>
<source>PLoS One</source>
<year>2011</year>
<volume>6</volume>
<fpage>e19881</fpage>
</nlm-citation>
</ref>
<ref id="ref5">
<label>5</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harikumar</surname>
<given-names>KB</given-names>
</name>
<name>
<surname>Aggarwal</surname>
<given-names>BB</given-names>
</name>
</person-group>
<article-title>Resveratrol: A multitargeted agent for age-associated chronic diseases</article-title>
<source>Cell Cycle</source>
<year>2008</year>
<volume>7</volume>
<fpage>1020</fpage>
<lpage>35</lpage>
</nlm-citation>
</ref>
<ref id="ref6">
<label>6</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Daffner</surname>
<given-names>KR</given-names>
</name>
</person-group>
<article-title>Promoting successful cognitive aging: A comprehensive review</article-title>
<source>J Alzheimers Dis</source>
<year>2010</year>
<volume>19</volume>
<fpage>1101</fpage>
<lpage>22</lpage>
</nlm-citation>
</ref>
<ref id="ref7">
<label>7</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Savouret</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Quesne</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Resveratrol and cancer: A review</article-title>
<source>Biomed Pharmacother</source>
<year>2002</year>
<volume>56</volume>
<fpage>84</fpage>
<lpage>7</lpage>
</nlm-citation>
</ref>
<ref id="ref8">
<label>8</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cao</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Potent induction of cellular antioxidants and phase 2 enzymes by resveratrol in cardiomyocytes: Protection against oxidative and electrophilic injury</article-title>
<source>Eur J Pharmacol</source>
<year>2004</year>
<volume>489</volume>
<fpage>39</fpage>
<lpage>48</lpage>
</nlm-citation>
</ref>
<ref id="ref9">
<label>9</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Rimando</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pallas</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Camins</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Porquet</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Reeves</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>
<article-title>Low-dose pterostilbene, but not resveratrol, is a potent neuromodulator in aging and Alzheimer&#x0027;s disease</article-title>
<source>Neurobiol Aging</source>
<year>2012</year>
<volume>33</volume>
<fpage>2062</fpage>
<lpage>71</lpage>
</nlm-citation>
</ref>
<ref id="ref10">
<label>10</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fr&#233;mont</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Biological effects of resveratrol</article-title>
<source>Life Sci</source>
<year>2000</year>
<volume>66</volume>
<fpage>663</fpage>
<lpage>73</lpage>
</nlm-citation>
</ref>
<ref id="ref11">
<label>11</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mizutani</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ikeda</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kawai</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yamori</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Resveratrol stimulates the proliferation and differentiation of osteoblastic MC3T3-E1 cells</article-title>
<source>Biochem Biophys Res Commun</source>
<year>1998</year>
<volume>253</volume>
<fpage>859</fpage>
<lpage>63</lpage>
</nlm-citation>
</ref>
<ref id="ref12">
<label>12</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dai</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Quarles</surname>
<given-names>LD</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>H</given-names>
</name>
<etal/>
</person-group>
<article-title>Resveratrol enhances proliferation and osteoblastic differentiation in human mesenchymal stem cells via ER-dependent ERK1/2 activation</article-title>
<source>Phytomedicine</source>
<year>2007</year>
<volume>14</volume>
<fpage>806</fpage>
<lpage>14</lpage>
</nlm-citation>
</ref>
<ref id="ref13">
<label>13</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Shang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group>
<article-title>Resveratrol augments the canonical Wnt signaling pathway in promoting osteoblastic differentiation of multipotent mesenchymal cells</article-title>
<source>Exp Cell Res</source>
<year>2009</year>
<volume>315</volume>
<fpage>2953</fpage>
<lpage>62</lpage>
</nlm-citation>
</ref>
<ref id="ref14">
<label>14</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zykova</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Zhai</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>WY</given-names>
</name>
<name>
<surname>Ermakova</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>KW</given-names>
</name>
<etal/>
</person-group>
<article-title>Resveratrol directly targets COX-2 to inhibit carcinogenesis</article-title>
<source>Mol Carcinog</source>
<year>2008</year>
<volume>47</volume>
<fpage>797</fpage>
<lpage>805</lpage>
</nlm-citation>
</ref>
<ref id="ref15">
<label>15</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhat</surname>
<given-names>KP</given-names>
</name>
<name>
<surname>Pezzuto</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>Cancer chemopreventive activity of resveratrol</article-title>
<source>Ann N Y Acad Sci</source>
<year>2002</year>
<volume>957</volume>
<fpage>210</fpage>
<lpage>29</lpage>
</nlm-citation>
</ref>
<ref id="ref16">
<label>16</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>B&#228;ckesj&#246;</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lindgren</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Haldos&#233;n</surname>
<given-names>LA</given-names>
</name>
</person-group>
<article-title>Activation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells</article-title>
<source>J Bone Miner Res</source>
<year>2006</year>
<volume>21</volume>
<fpage>993</fpage>
<lpage>1002</lpage>
</nlm-citation>
</ref>
<ref id="ref17">
<label>17</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boissy</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Andersen</surname>
<given-names>TL</given-names>
</name>
<name>
<surname>Abdallah</surname>
<given-names>BM</given-names>
</name>
<name>
<surname>Kassem</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Plesner</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Delaiss&#233;</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>Resveratrol inhibits myeloma cell growth, prevents osteoclast formation, and promotes osteoblast differentiation</article-title>
<source>Cancer Res</source>
<year>2005</year>
<volume>65</volume>
<fpage>9943</fpage>
<lpage>52</lpage>
</nlm-citation>
</ref>
<ref id="ref18">
<label>18</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ducy</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Geoffroy</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Ridall</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Karsenty</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation</article-title>
<source>Cell</source>
<year>1997</year>
<volume>89</volume>
<fpage>747</fpage>
<lpage>54</lpage>
</nlm-citation>
</ref>
<ref id="ref19">
<label>19</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jaiswal</surname>
<given-names>RK</given-names>
</name>
<name>
<surname>Jaiswal</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Bruder</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Mbalaviele</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Marshak</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Pittenger</surname>
<given-names>MF</given-names>
</name>
</person-group>
<article-title>Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase</article-title>
<source>J Biol Chem</source>
<year>2000</year>
<volume>275</volume>
<fpage>9645</fpage>
<lpage>52</lpage>
</nlm-citation>
</ref>
<ref id="ref20">
<label>20</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mizutani</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ikeda</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kawai</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yamori</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Resveratrol attenuates ovariectomy-induced hypertension and bone loss in stroke-prone spontaneously hypertensive rats</article-title>
<source>J Nutr Sci Vitaminol (Tokyo)</source>
<year>2000</year>
<volume>46</volume>
<fpage>78</fpage>
<lpage>83</lpage>
</nlm-citation>
</ref>
<ref id="ref21">
<label>21</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>YX</given-names>
</name>
<name>
<surname>Janakiraman</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Chapman</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Gautam</surname>
<given-names>SC</given-names>
</name>
</person-group>
<article-title>Immunomodulatory activity of resveratrol: Suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production</article-title>
<source>Biochem Pharmacol</source>
<year>2001</year>
<volume>62</volume>
<fpage>1299</fpage>
<lpage>308</lpage>
</nlm-citation>
</ref>
<ref id="ref22">
<label>22</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manna</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Mukhopadhyay</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Aggarwal</surname>
<given-names>BB</given-names>
</name>
</person-group>
<article-title>Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: Potential role of reactive oxygen intermediates and lipid peroxidation</article-title>
<source>J Immunol</source>
<year>2000</year>
<volume>164</volume>
<fpage>6509</fpage>
<lpage>19</lpage>
</nlm-citation>
</ref>
<ref id="ref23">
<label>23</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bi</surname>
<given-names>XL</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>YX</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>YH</given-names>
</name>
<name>
<surname>Ikeshima</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group>
<article-title>Resveratrol inhibits nitric oxide and TNF-alpha production by lipopolysaccharide-activated microglia</article-title>
<source>Int Immunopharmacol</source>
<year>2005</year>
<volume>5</volume>
<fpage>185</fpage>
<lpage>93</lpage>
</nlm-citation>
</ref>
<ref id="ref24">
<label>24</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kowalski</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Samojedny</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Paul</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pietsz</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Wilczok</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Effect of apigenin, kaempferol and resveratrol on the expression of interleukin-1beta and tumor necrosis factor-alpha genes in J774.2 macrophages</article-title>
<source>Pharmacol Rep</source>
<year>2005</year>
<volume>57</volume>
<fpage>390</fpage>
<lpage>4</lpage>
</nlm-citation>
</ref>
<ref id="ref25">
<label>25</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Issuree</surname>
<given-names>PD</given-names>
</name>
<name>
<surname>Pushparaj</surname>
<given-names>PN</given-names>
</name>
<name>
<surname>Pervaiz</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Melendez</surname>
<given-names>AJ</given-names>
</name>
</person-group>
<article-title>Resveratrol attenuates C5a-induced inflammatory responses <italic>in vitro</italic> and <italic>in vivo</italic> by inhibiting phospholipase D and sphingosine kinase activities</article-title>
<source>FASEB J</source>
<year>2009</year>
<volume>23</volume>
<fpage>2412</fpage>
<lpage>24</lpage>
</nlm-citation>
</ref>
<ref id="ref26">
<label>26</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Zou</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>Effect of resveratrol on platelet aggregation <italic>in vivo</italic> and <italic>in vitro</italic></article-title>
<source>Chin Med J (Engl)</source>
<year>2002</year>
<volume>115</volume>
<fpage>378</fpage>
<lpage>80</lpage>
</nlm-citation>
</ref>
<ref id="ref27">
<label>27</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wung</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Hsu</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Hsieh</surname>
<given-names>CW</given-names>
</name>
</person-group>
<article-title>Resveratrol suppresses IL-6-induced ICAM-1 gene expression in endothelial cells: Effects on the inhibition of STAT3 phosphorylation</article-title>
<source>Life Sci</source>
<year>2005</year>
<volume>78</volume>
<fpage>389</fpage>
<lpage>97</lpage>
</nlm-citation>
</ref>
<ref id="ref28">
<label>28</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Jeong</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Bae</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>WS</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>SD</given-names>
</name>
<etal/>
</person-group>
<article-title>Resveratrol inhibits Porphyromonas gingivalis lipopolysaccharide-induced endothelial adhesion molecule expression by suppressing NF-kappaB activation</article-title>
<source>Arch Pharm Res</source>
<year>2009</year>
<volume>32</volume>
<fpage>583</fpage>
<lpage>91</lpage>
</nlm-citation>
</ref>
<ref id="ref29">
<label>29</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lerner</surname>
<given-names>UH</given-names>
</name>
<name>
<surname>H&#228;nstr&#246;m</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Sj&#246;str&#246;m</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Stimulation of bone resorption and cell proliferation <italic>in vitro</italic> by human gingival fibroblasts from patients with periodontal disease</article-title>
<source>Bone Miner</source>
<year>1990</year>
<volume>10</volume>
<fpage>225</fpage>
<lpage>42</lpage>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
